PROCEPT BioRobotics Corporation Foreign Currency Transaction Gain Loss Realized After Tax
PROCEPT BioRobotics Corporation (PRCT) reported Foreign Currency Transaction Gain Loss Realized After Tax of -$431.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossRealizedAfterTax · last filed 2026-08-05
- PROCEPT BioRobotics Corporation foreign currency transaction gain loss realized after tax for the quarter ending 2026-06-30 was -$134.00K, a 138.51% decline year-over-year.
- PROCEPT BioRobotics Corporation foreign currency transaction gain loss realized after tax for the quarter ending 2026-03-31 was -$297.00K.
- PROCEPT BioRobotics Corporation foreign currency transaction gain loss realized after tax for the quarter ending 2025-09-30 was -$227.00K.
- PROCEPT BioRobotics Corporation foreign currency transaction gain loss realized after tax for the quarter ending 2025-06-30 was $348.00K.
| Period end | Foreign Currency Transaction Gain Loss Realized After Tax 3 month | Foreign Currency Transaction Gain Loss Realized After Tax 6 month | Foreign Currency Transaction Gain Loss Realized After Tax 9 month |
|---|---|---|---|
| 2026-06-30 | -$134.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$431.00K 10-Q · filed 2026-08-05 | |
| 2026-03-31 | -$297.00K 10-Q · filed 2026-04-30 | ||
| 2025-09-30 | -$227.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $121.00K derived: sum of 2 quarters · filed 2026-08-05 | $121.00K 10-Q · filed 2025-11-05 |
| 2025-06-30 | $348.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $348.00K 10-Q · filed 2026-08-05 | |
| 2025-03-31 | $0.00 10-Q · filed 2026-04-30 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $0.00 10-Q · filed 2025-11-05 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |